The global BRAF Kinase Inhibitors Market is estimated to be valued at US$ 924.8 million in 2020 and is expected to exhibit a CAGR of 8.6% over the forecast period, 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
BRAF kinase inhibitors are a class of targeted therapy drugs used in the treatment of various types of cancer, including melanoma and colorectal cancer. These inhibitors work ... Read more
